Peptide Therapy: Cagrilintide Lebanon, TN Efficacy and safety of co administered once weekly cagrilintide 24 mg with once weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double blind, active controlled, phase 2 trial The Lancet Research Peptide Spotlight: Calgri (Cagrilintide) is here! The long acting amylin analog that's blowing up in metabolic research. This powerhouse mimics your body's natural satiety hormone, helping dial down appetite and support Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet